Chemokines and cutaneous lymphoma

Journal of Dermatological Science

Volumn 59, Issue 2, 2010, Pages 81-85

  Sugaya, Makoto ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

CCL17; CCL26; CCL27; Chemokines; Cutaneous lymphoma; CXCL13

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR CCR10; CHEMOKINE RECEPTOR CCR4; CUTANEOUS T CELL ATTRACTING CHEMOKINE; CXCL13 CHEMOKINE; CXCL9 CHEMOKINE; EOTAXIN; EOTAXIN 3; GAMMA INTERFERON INDUCIBLE PROTEIN 10; THYMUS AND ACTIVATION REGULATED CHEMOKINE;

B LYMPHOCYTE; DISEASE ACTIVITY; DISEASE COURSE; EPIDERMOTROPISM; HUMAN; IMMUNOPATHOGENESIS; LYMPH FOLLICLE; LYMPHOCYTE PROLIFERATION; LYMPHOCYTIC INFILTRATION; MYCOSIS FUNGOIDES; PRIORITY JOURNAL; REVIEW; SEZARY SYNDROME; SKIN LYMPHOMA; T CELL LYMPHOMA; TH2 CELL;

CHEMOKINES; DISEASE PROGRESSION; HUMANS; LYMPHOMA, T-CELL, CUTANEOUS; RECEPTORS, CHEMOKINE; SKIN NEOPLASMS;

EID: 77955050682     PISSN: 09231811     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2010.05.005     Document Type: Review

References (49)

1. Charo I.F., Ransohoff R.M. The many roles of chemokines and chemokine receptors in inflammation. N Engl J Med 2006, 354:610-621.
2. Murakami T., Cardones A.R., Finkelstein S.E., Restifo N.P., Klaunberg B.A., Nestle F.O., et al. Immune evasion by murine melanoma mediated through CC chemokine receptor-10. J Exp Med 2003, 198:1337-1347.
3. Saeki H., Tamaki K. Thymus and activation regulated chemokine (TARC)/CCL17 and skin diseases. J Dermatol Sci 2006, 43:75-84.
4. Swerdlow S.H., Campo E., Harris N.L., Jaffe E.S., Pileri S.A., Stein H., et al. WHO classification of tumours of haematopoietic and lymphoid tissues 2008, IARC Press, Lyon.
5. Sarris A.H., Esgleyes-Ribot T., Crow M., Broxmeyer H.E., Karasavvas N., Pugh W., et al. Cytokine loops involving interferon-gamma and IP-10, a cytokine chemotactic for CD4+ lymphocytes: an explanation for the epidermotropism of cutaneous T-cell lymphoma?. Blood 1995, 86:651-658.
6. Lu D., Duvic M., Medeiros L.J., Luthra R., Dorfman D.M., Jones D. The T-cell chemokine receptor CXCR3 is expressed highly in low-grade mycosis fungoides. Am J Clin Pathol 2001, 115:413-421.
7. Kallinich T., Muche J.M., Qin S., Sterry W., Audring H., Kroczek R.A., et al. Chemokine receptor expression on neoplastic and reactive T cells in the skin at different stages of mycosis fungoides. J Invest Dermatol 2003, 121:1045-1052.
8. Yamaguchi T., Ohshima K., Tsuchiya T., Suehuji H., Karube K., Nakayama J., et al. The comparison of expression of cutaneous lymphocyte-associated antigen (CLA), and Th1- and Th2-associated antigens in mycosis fungoides and cutaneous lesions of adult T-cell leukemia/lymphoma. Eur J Dermatol 2003, 13:553-559.
9. Yagi H., Seo N., Ohshima A., Itoh T., Itoh N., Horibe T., et al. Chemokine receptor expression in cutaneous T cell and NK/T-cell lymphomas: immunohistochemical staining and in vitro chemotactic assay. Am J Surg Pathol 2006, 30:1111-1119.
10. Kakinuma T., Sugaya M., Nakamura K., Kaneko F., Wakugawa M., Matsushima K., et al. Thymus and activation-regulated chemokine (TARC/CCL17) in mycosis fungoides: serum TARC levels reflect the disease activity of mycosis fungoides. J Am Acad Dermatol 2003, 48:23-30.
11. Ferenczi K., Fuhlbrigge R.C., Pinkus J., Pinkus G.S., Kupper T.S. Increased CCR4 expression in cutaneous T cell lymphoma. J Invest Dermatol 2002, 119:1405-1410.
12. Fujita Y., Abe R., Sasaki M., Honda A., Furuichi M., Asano Y., et al. Presence of circulating CCR10+ T cells and elevated serum CTACK/CCL27 in the early stage of mycosis fungoides. Clin Cancer Res 2006, 12:2670-2675.
13. Sokolowska-Wojdylo M., Wenzel J., Gaffal E., Lenz J., Speuser P., Erdmann S., et al. Circulating clonal CLA(+) and CD4(+) T cells in Sézary syndrome express the skin-homing chemokine receptors CCR4 and CCR10 as well as the lymph node-homing chemokine receptor CCR7. Br J Dermatol 2005, 152:258-264.
14. Capriotti E., Vonderheid E.C., Thoburn C.J., Bright E.C., Hess A.D. Chemokine receptor expression by leukemic T cells of cutaneous T-cell lymphoma: clinical and histopathological correlations. J Invest Dermatol 2007, 127:2882-2892.
15. Narducci M.G., Scala E., Bresin A., Caprini E., Picchio M.C., Remotti D., et al. Skin homing of Sézary cells involves SDF-1-CXCR4 signaling and down-regulation of CD26/dipeptidylpeptidase IV. Blood 2006, 107:1108-1115.
16. Legler D.F., Loetscher M., Roos R.S., Clark Lewis I., Baggiolini M., Moser B. B cell-attracting chemokine 1, a human CXC chemokine expressed in lymphoid tissue, selectively attracts B lymphocytes via BLR1/CXCR5. J Exp Med 1998, 187:655-660.
17. Forster R., Emrich T., Kremmer E., Lipp M. Expression of the G-protein-coupled receptor BLR1 defines mature, recirculating B cells and a subset of T-helper memory cells. Blood 1994, 84:830-840.
18. Gunn M.D., Ngo V.N., Ansel K.M., Ekland E.H., Cyster J.G., Williams L.T. A B-cell-homing chemokines made in lymphoid follicles activates Burkitt's lymphoma receptor-1. Nature 1998, 391:799-803.
19. Ansel K.M., Ngo V.N., Hyman P.L., Luther S.A., Forster R., Sedgwick J.D., et al. A chemokine-driven positive feedback loop organizes lymphoid follicles. Nature 2000, 406:309-314.
20. Mazzucchelli L., Blaser A., Kappeler A., Scharli P., Laissue J.A., Baggiolini M., et al. BCA-1 is highly expressed in Helicobacter pylori-induced mucosa-associated lymphoid tissue and gastric lymphoma. J Clin Invest 1999, 104:R49-54.
21. Smith J.R., Braziel R.M., Paoletti S., Lipp M., Uguccioni M., Rosenbaum J.T. Expression of B-cell-attracting chemokine 1 (CXCL13) by malignant lymphocytes and vascular endothelium in primary central nervous system lymphoma. Blood 2003, 101:815-821.
22. Ohmatsu H., Sugaya M., Kadono T., Tamaki K. CXCL13 and CCL21 are expressed in ectopic lymphoid follicles in cutaneous lymphoproliferative disorders. J Invest Dermatol 2007, 127:2466-2468.
23. Dupuis J., Boye K., Martin N., Copie-Bergman C., Plonquet A., Fabiani B., et al. Expression of CXCL13 by neoplastic cells in angioimmunoblastic T-cell lymphoma (AITL): a new diagnostic marker providing evidence that AITL derives from follicular helper T cells. Am J Surg Pathol 2006, 30:490-494.
24. Rodríguez Pinilla S.M., Roncador G., Rodríguez-Peralto J.L., Mollejo M., García J.F., Montes-Moreno S., et al. Primary cutaneous CD4+ small/medium-sized pleomorphic T-cell lymphoma expresses follicular T-cell markers. Am J Surg Pathol 2009, 33:81-90.
25. Huang Y., Moreau A., Dupuis J., Streubel B., Petit B., Le Gouill S., et al. Peripheral T-cell lymphomas with a follicular growth pattern are derived from follicular helper T cells (TFH) and may show overlapping features with angioimmunoblastic T-cell lymphomas. Am J Surg Pathol 2009, 33:682-690.
26. Loetscher M., Gerber B., Loetscher P., Jones S.A., Piali L., Clark-Lewis I., et al. Chemokine receptor specific for IP10 and Mig: structure, function, and expression in activated T-lymphocytes. J Exp Med 1996, 184:963-969.
27. Albanesi C., Scarponi C., Sebastiani S., Cavani A., Federici M., De Pità O., et al. IL-4 enhances keratinocyte expression of CXCR3 agonistic chemokines. J Immunol 2000, 165:1395-1402.
28. Fujita H., Asahina A., Sugaya M., Nakamura K., Gao P., Fujiwara H., et al. Differential production of Th1- and Th2-type chemokines by mouse Langerhans cells and splenic dendritic cells. J Invest Dermatol 2005, 124:343-350.
29. Tensen C.P., Vermeer M.H., van der Stoop P.M., van Beek P., Scheper R.J., Boorsma D.M., et al. Epidermal interferon-gamma inducible protein-10 (IP-10) and monokine induced by gamma-interferon (Mig) but not IL-8 mRNA expression is associated with epidermotropism in cutaneous T cell lymphomas. J Invest Dermatol 1998, 111:222-226.
30. Inngjerdingen M., Damaj B., Maghazachi A.A. Human NK cells express CC chemokine receptors 4 and 8 and respond to thymus and activation-regulated chemokine, macrophage-derived chemokine, and I-309. J Immunol 2000, 164:4048-4054.
31. Masui Y., Sugaya M., Kagami S., Fujita H., Yano S., Nagao M., et al. Sézary syndrome treated with narrowband ultraviolet B: time-course measurement of serum levels of CCL17/CCL27. Clin Exp Dermatol 2007, 32:57-59.
32. Morales J., Homey B., Vicari A.P., Hudak S., Oldham E., Hedrick J., et al. CTACK, a skin-associated chemokine that preferentially attracts skin-homing memory T cells. Proc Natl Acad Sci USA 1999, 96:14470-14475.
33. Homey B., Alenius H., Müller A., Soto H., Bowman E.P., Yuan W., et al. CCL27-CCR10 interactions regulate T cell-mediated skin inflammation. Nat Med 2002, 8:157-165.
34. Kakinuma T., Saeki H., Tsunemi Y., Fujita H., Asano N., Mitsui H., et al. Increased serum cutaneous T cell-attracting chemokine (CCL27) levels in patients with atopic dermatitis and psoriasis vulgaris. J Allergy Clin Immunol 2003, 111:592-597.
35. Kagami S., Sugaya M., Minatani Y., Ohmatsu H., Kakinuma T., Fujita H., et al. Elevated serum CTACK/CCL27 levels in C.T.C.L. J Invest Dermatol 2006, 126:1189-1191.
36. Yamaguchi T., Ohshima K., Karube K., Kawano R., Nakayama J., Suzumiya J., et al. Expression of chemokines and chemokine receptors in cutaneous CD30+ lymphoproliferative disorders. Br J Dermatol 2006, 154:904-909.
37. Yoshie O., Fujisawa R., Nakayama T., Harasawa H., Tago H., Izawa D., et al. Frequent expression of CCR4 in adult T-cell leukemia and human T-cell leukemia virus type 1-transformed T cells. Blood 2002, 99:1505-1511.
38. Forssmann U., Uguccioni M., Loetscher P., Dahinden C.A., Langen H., Thelen M., et al. Eotaxin-2, a novel CC chemokine that is selective for the chemokine receptor CCR3, and acts like eotaxin on human eosinophil and basophil leukocytes. J Exp Med 1997, 185:2171-2176.
39. Sallusto F., Mackay C.R., Lanzavecchia A. Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells. Science 1997, 277:2005-2007.
40. Kleinhans M., Tun-Kyi A., Gilliet M., Kadin M.E., Dummer R., Burg G., et al. Functional expression of the eotaxin receptor CCR3 in CD30+ cutaneous T-cell lymphoma. Blood 2003, 101:1487-1493.
41. Berkman N., Ohnona S., Chung F.K., Breuer R. Eotaxin-3 but not eotaxin gene expression is upregulated in asthmatics 24hours after allergen challenge. Am J Respir Cell Mol Biol 2001, 24:682-687.
42. Kagami S., Kakinuma T., Saeki H., Tsunemi Y., Fujita H., Nakamura K., et al. Significant elevation of serum levels of eotaxin-3, but not of eotaxin-2/CCL24, in patients with atopic dermatitis: serum eotaxin-3 levels reflect the disease activity of atopic dermatitis. Clin Exp Immunol 2003, 134:309-313.
43. Teruya-Feldstein J., Jaffe E.S., Burd P.R., Kingma D.W., Setsuda J.E., Tosato G. Differential chemokine expression in tissues involved by Hodgkin's disease: direct correlation of eotaxin expression and tissue eosinophilia. Blood 1999, 93:2463-2470.
44. Jundt F., Anagnostopoulos I., Bommert K., Emmerich F., Müller G., Foss H.D., et al. Hodgkin/Reed-Sternberg cells induce fibroblasts to secrete eotaxin, a potent chemoattractant for T cells and eosinophils. Blood 1999, 94:2065-2071.
45. Vowels B.R., Lessin S.R., Cassin M., Jaworsky C., Benoit B., Wolfe J.T., et al. Th2 cytokine mRNA expression in skin in cutaneous T-cell lymphoma. J Invest Dermatol 1994, 103:669-673.
46. Dummer R., Heald P.W., Nestle F.O., Ludwig E., Laine E., Hemmi S., et al. Sézary syndrome T-cell clones display T-helper 2 cytokines and express the accessory factor-1 (interferon-gamma receptor beta-chain). Blood 1996, 88:1383-1389.
47. Urosevic M., Fujii K., Calmels B., Laine E., Kobert N., Acres B., et al. Type I IFN innate immune response to adenovirus-mediated IFN-gamma gene transfer contributes to the regression of cutaneous lymphomas. J Clin Invest 2007, 117:2834-2846.
48. Miyagaki T, Sugaya M, Fujita H, Ohmatsu H, Kakinuma T, Kadono T, et al. Eotaxins and CCR3 interaction regulates Th2 environment of cutaneous T cell lymphoma. J Invest Dermatol, 2010 May 27. [Epub ahead of print], doi:10.1038/jid.2010.128.
49. Ishii T., Ishida T., Utsunomiya A., Inagaki A., Yano H., Komatsu H., et al. Defucosylated humanized anti-CCR4 monoclonal antibody KW-0761 as a novel immunotherapeutic agent for adult T-cell leukemia/lymphoma. Clin Cancer Res 2010, 16:1520-1531.